Alpha 2.0
Login Register
» Authors » Hugo Acosta

Hugo Acosta

Explore the profile of Hugo Acosta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 31
Followers 0
Related Specialties
Allergy & Immunology
General Medicine
Science
Top 10 Co-Authors
Ali Fattom
Douglas Smith
Jesse Chen
Stephen J Streatfield
Shyamala Ganesan
Zhengyi Cao
Su He Wang
Charles Chen
James R Baker Jr
Susan Ciotti
Published In
Vaccine
PLoS One
Affiliations
Soon will be listed here.
Recent Articles
1.
Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice
Ganesan S, Acosta H, Brigolin C, Orange K, Trabbic K, Chen C, et al.
PLoS One . 2022 Nov; 17(11):e0272594. PMID: 36322572
With the rapid progress made in the development of vaccines to fight the SARS-CoV-2 pandemic, almost >90% of vaccine candidates under development and a 100% of the licensed vaccines are...
2.
A novel combination of intramuscular vaccine adjuvants, nanoemulsion and CpG produces an effective immune response against influenza A virus
Wang S, Chen J, Smith D, Cao Z, Acosta H, Fan Y, et al.
Vaccine . 2020 Apr; 38(19):3537-3544. PMID: 32245642
Background: Vaccination is the most effective approach to prevent infection with highly pathogenic avian influenza (HPAI). Adjuvants are often used to induce effective immune responses and overcome the immunological weakness...
3.
A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge
Smith D, Streatfield S, Acosta H, Ganesan S, Fattom A
Vaccine . 2019 Sep; 37(42):6162-6170. PMID: 31495593
Background: Flu vaccines administered intramuscularly (IM) have shown seasonally fluctuating efficacy, 20-60%, throughout the last 15 years. We formulated a recombinant H5 (rH5) in our Nanovax® (NE01) (rH5/NE01) adjuvant for...
4.
Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge
Wang S, Smith D, Cao Z, Chen J, Acosta H, Chichester J, et al.
Vaccine . 2019 Feb; 37(12):1591-1600. PMID: 30795941
Background: Highly pathogenic H5N1 influenza viruses remain a pandemic risk to the world population. Although vaccines are the best solution to prevent this threat, a more effective vaccine for H5...